Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 2, 2002, Pages 927-937

  Goldstone, Anthony P ^a   Unmehopa, Unga A ^a   Bloom, Stephen R ^b   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y;

ADULT; AGED; ANOREXIA; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; FEMALE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE CELL NETWORK; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGOUTI; ANIMALIA;

EID: 0036172575     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.2.8230     Document Type: Article

References (66)

1. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
2. Central effects of neuropeptide Y with emphasis on its role in obesity and diabetes
3. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
4. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
5. Unraveling the central nervous system pathways underlying responses to leptin
6. Metabolic control of sexual function and growth: Role of neuropeptide Y and leptin
7. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin
8. Neuroendocrine responses to starvation and weight loss
9. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
10. Hypocretin/orexinand melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and Agouti gene-related protein systems
11. Hypothalamic localization of the feeding effect of agouti-related peptide and α-melanocyte-stimulating hormone
12. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with non-thyroidal illness
13. Anterior pituitary function during critical illness and dopamine treatment
14. Anorexia in response to acute illness
15. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
16. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity
17. Genetics of body-weight regulation
18. Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity
19. Prader-Willi syndrome: Consensus diagnostic criteria
20. Imprinting in Prader-Willi and Angelman syndromes
21. Prader-Willi syndrome and the hypothalamus
22. Effect of regional fat distribution and Prader Willi syndrome on plasma leptin levels
23. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome
24. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
25. Incriminating gene suspects. Prader-Willi style
26. A mouse model for Prader-Willi syndrome imprinting-centre mutations
27. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome
28. Differential expression of the neuroendocrine polypeptide 7B2 in hypothalami of Prader-(Labhart)-Willi syndrome patients
29. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: A study of five cases
30. Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: Indications for a processing defect
31. Fc-mediated nonspecific staining of the porcine brain with rabbit antisera in immunocytochemistry is prevented by pre-incubation of the sera with proteins A and G
32. Sex- and age-related P75 neurotrophin receptor expression in the human supraoptic nucleus
33. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression
34. Genes encoding pancreatic polypeptide and neuropeptide Y are on human chromosomes 17 and 7
35. Simultaneous detection of tyrosine hydroxylase-immunoreactivity and vasopressin mRNA in neurons of the human paraventricular and supraoptic nucleus
36. Brain banking and the human hypothalamus - Factors to match for, pitfalls and potentials
37. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone
38. Regional distribution of neuropeptide Y-like immunoreactivity in human hypothalamus measured by immunoradiometric assay: Possible influence of chronic respiratory failure on tissue levels
39. Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: Characterization of brain cytokine and neuropeptide systems mRNAs
40. Alterations in hypothalamic NPY and CRF in anorexic tumor- bearing rats
41. Plasma leptin in chronic inflammatory bowel disease and HIV: Implications for the pathogenesis of anorexia and weight loss
42. Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis
43. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting
44. Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin
45. Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats
46. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats
47. Agouti-related protein is a mediator of diabetic hyperphagia
48. Role of central melanocortins in endotoxin-induced anorexia
49. Role of leptin in the neuroendocrine response to fasting
50. Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat
51. Morphological evidence for direct interaction between arcuate nucleus neuropeptide Y (NPY) neurons and gonadotropin-releasing hormone neurons and the possible involvement of NPY Y1 receptors
52. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
53. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
54. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
55. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
56. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice
57. Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus
58. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome
59. Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice
60. Postmortem anterograde tracing of intrahypothalamic projections of the human dorsomedial nucleus of the hypothalamus
61. Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: Evidence for a hypothalamic site for concurrent development of leptin resistance
62. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain
63. Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain
64. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia
65. IL-1β immunoreactive neurons in the human hypothalamus: Reduced numbers in multiple sclerosis
66. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene